The company behind Claude once promised to build safe and ethical tech. Pete Hegseth is putting that promise to the test.
Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results